Recurrence beyond Milan criteria predicts worse outcomes after hepatocellular carcinoma resection. Limited recurrence remains manageable.

Liver resection should be the primary therapeutic option for patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for transplant, a retrospective cohort study suggested.

For patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for liver transplant, liver resection provides a survival advantage over percutaneous radiofrequency ablation and ...

A multicenter prospective study to evaluate the efficacy of resection for initially unresectable hepatocellular carcinoma after atezolizumab combined with bevacizumab (the RACB study). Preliminary ...

A phase III randomized clinical trial evaluating perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB). This is an ASCO Meeting ...

In a new study published in Liver Research, a team of researchers in China discovered that nicotinic acid—a common form of vitamin B3—can dramatically ...

The transplanted portion of the genetically modified pig liver was removed after 38 days, and the patient, who had advanced liver cancer and cirrhosis, died several months later. By Roni Caryn Rabin ...